Eric A Hughes, EVP, Global R&D and Chief Medical Officer at Teva Pharmaceutical, holds 0.00 shares in Teva Pharmaceutical (Ticker: TEVA), holds ― shares in Monte Rosa Therapeutics (Ticker: GLUE). Most recently, Eric A Hughes Sold ― shares of Teva Pharmaceutical on Aug 13, 2024 for an estimated value of 782.69K.
What is the percentage of profitable transactions made by Eric A Hughes?
The percentage of profitable transactions made by Eric A Hughes is ―.
What is the average return per transaction made by Eric A Hughes?
The average return per transaction made by Eric A Hughes is ―.
What stocks does Eric A Hughes hold?
Eric A Hughes holds: TEVA, GLUE stocks.
What was Eric A Hughes’s latest transaction?
Eric A Hughes latest transaction was an Informative Sell of $782.69K.
What was Eric A Hughes's most profitable transaction?
Eric A Hughes’s most profitable transaction was an Informative Sell of TEVA stock on August 13, 2024. The return on the trade was -1.10%.
What is Eric A Hughes's role in Teva Pharmaceutical?
Eric A Hughes's role in Teva Pharmaceutical is EVP, Global R&D and Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.